Characterization of the SGLT2 interaction network and its regulation by SGLT2 inhibitors: a bioinformatic analysis

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Anna Nowak

Medical University of Warsaw, Warsaw (Poland)

6 More presentations in this session

Presentation thumbnail

Absolute treatment effects of novel oral antidiabetic drugs on cardiovascular mortality and hospitalization for heart failure: a meta-analysis of digitalized individual patient outcomes

Mr G. Wolff (Ibbenbüren, DE)

Abstract Slides

Presentation thumbnail

The gender gap in prescription pattern of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes

Mr A. Hammer (Vienna, AT)

Abstract Slides

Presentation thumbnail

Pharmacological selectivity of SGLT2 inhibitors and cardiovascular outcomes in patients with type 2 diabetes: a meta-analysis

Doctor A. Sayour (Budapest, HU)

Abstract Slides

Presentation thumbnail

Impact of SGLT2 inhibitor on mortality and cardiovascular outcomes in patients with type 2 diabetes mellitus with left main or multivessel coronary artery disease

Doctor D. Chipayo Gonzales (Caceres, ES)

Abstract Slides

Presentation thumbnail

Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes patients: a propensity score-matched study

Mr O. Chou (Hong Kong, HK)

Abstract Slides

Access the full session

Session thumbnail

SGLT2 inhibitors in clinical practice

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting

Congress Presentation

Hypertension and glucose

Congress Presentation

Cardiovascular risk reduction: should we target pre-diabetes?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources